American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 814-823, June 2007

Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis

  • Larry A. Greenbaum, MD, PhD

      Affiliations

    • Emory University and Children’s Healthcare of Atlanta, GA
    • Corresponding Author InformationAddress correspondence to Larry Greenbaum, MD, PhD, Emory University and Children’s Healthcare of Atlanta, GA 30322.
    • ,
  • Nadine Benador, MD

      Affiliations

    • University of California at San Diego, La Jolla
    • ,
  • Stuart L. Goldstein, MD

      Affiliations

    • Baylor College of Medicine/Texas Children’s Hospital, Houston, TX
    • ,
  • Ana Paredes, MD

      Affiliations

    • Miami Children’s Hospital, Miami, FL
    • ,
  • Joel Z. Melnick, MD

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Susan Mattingly, BSN

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Michael Amdahl, MS

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Laura A. Williams, MD, MPH

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Isidro B. Salusky, MD

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angeles, CA.

Received 31 October 2006; accepted 13 March 2007. published online 04 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2007.03.008 on May 4, 2007.

 Support: This study was funded by Abbott Laboratories. Potential conflicts of interest: Dr Williams, Dr Melnick, and Mr. Amdahl are employees of Abbott Laboratories, the manufacturer of paricalcitol.

PII: S0272-6386(07)00640-3

doi:10.1053/j.ajkd.2007.03.008

American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 814-823, June 2007

Article Tools

* Image Usage & Resolution